Treatment of Hypertension With Adalat® in Combination With Other Drugs

CompletedOBSERVATIONAL
Enrollment

4,497

Participants

Timeline

Start Date

January 31, 2010

Study Completion Date

September 30, 2011

Conditions
Hypertension
Interventions
DRUG

Nifedipine (Adalat, BAYA1040)

Previously untreated hypertensive adult patients starting with combination therapy containing nifedipine or insufficiently controlled hypertensive patients receiving nifedipine as an add-on to existing non-CCB containing antihypertensive therapy. The decision of including the patient as well as decision on dosage and duration is taken by the investigator.

Trial Locations (11)

Unknown

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY